- CIIX subsidiary CBD Biotech Inc. has expanded into seven powerful Asian markets
- The Southeast Asia e-commerce market is projected to reach $230 billion by 2025
- Via Shopee, the company has access to over seven million active buyers across multiple countries
ChineseInvestors.com Inc. (OTCQB: CIIX), a provider of financial information and services to a global Chinese speaking community, announced that its wholly owned subsidiary, CBD Biotech Inc., has expanded into six new countries and a new region of China (http://ibn.fm/CbhnZ) – seven significant markets. While CIIX is still focused on its original mission of providing financial information in the Chinese language character sets, its subsidiary is making a name for itself in the emerging global CBD market.
CBD Biotech has created a product line designed for the international Chinese market. The announcement of the subsidiary’s expansion follows on the heels of six new hemp-infused skincare products that were designed and launched to increase brand loyalty and awareness (http://ibn.fm/MNwe0). As additional product launches are already being planned, CBD Biotech appears to be assertively riding the wave of the burgeoning cannabis market.
“We expect to continue this momentum with the anticipated launch of three additional skincare products before the end of 2019,” CBD Biotech Chief Financial Officer Alex Hamilton stated in a news release. “As a first mover in the CBD skincare industry in China, we are encouraged by U.S. market trends in the last year, which we believe strengthens the overall acceptance of CBD, including the passage of the 2018 Farm Bill which authorizes the sale of many CBD products, including skin-care and cosmetic products, and the recently announced acquisition of Lord Jones (private) by Cronos Group (NASDAQ: CRON) for $300 million. We believe we are moving in the right direction, in the right markets.”
CBD Biotech does seem to be moving into the right spaces at the right time, and credits its recent expansion to its newest sales channel, Shopee. A popular Singaporean e-commerce platform, Shopee boasts four million registered businesses, 200 million app downloads, 30 million social media fans and over seven million active buyers. It is currently the largest e-commerce platform in Southeast Asia and is tapping into a quickly growing e-commerce market, one that is expected to reach $230 billion by 2025 (http://ibn.fm/650ti).
“This dynamic and very popular platform in Southeast Asia has allowed CBD Biotech to execute on our plans for expansion throughout Asia,” stated Hamilton. “Thanks to Shopee, we are now in seven major markets: Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines and Taiwan, China.”
The expansion through Shopee is a vital part of the company’s strategic plan to build a loyal customer base while also expanding geographically. CBD Biotech is committed to meeting the same high standards that CIIX has held since its inception. As CBD Biotech CEO Summer Yun noted the company’s goal, he hopes that “when one thinks of CBD skincare/cosmetics, CBD Biotech is the first name that comes to mind.”
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
